• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015/16年度中国北京流感疫苗对流感相关住院治疗的有效性

Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.

作者信息

Zhang Yi, Wu Peng, Feng Luzhao, Yang Peng, Pan Yang, Feng Shuo, Qin Ying, Zheng Jiandong, Puig-Barberà Joan, Muscatello David, MacIntyre Raina, Cowling Benjamin J, Yu Hongjie, Wang Quanyi

机构信息

Institute of Infectious Diseases and Endemic Diseases Control, Beijing Center for Disease Prevention and Control, Beijing, China; School of Public Health and Community Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.

School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.

出版信息

Vaccine. 2017 May 25;35(23):3129-3134. doi: 10.1016/j.vaccine.2017.03.084. Epub 2017 Apr 26.

DOI:10.1016/j.vaccine.2017.03.084
PMID:28456530
Abstract

BACKGROUND

Vaccination is recommended to prevent influenza virus infection and associated complications. This study aimed to estimate the influenza vaccine effectiveness (VE) against hospitalization in the 2015/16 season in Beijing.

METHODS

Patients who were hospitalized in the 5 study hospitals between 1 Oct 2015 and 15 May 2016 were recruited. Influenza vaccination status was obtained for PCR-confirmed influenza patients and the selected controls who tested negative for the virus. Conditional logistic regression was used to estimate the influenza VE matching by calendar week, and adjusting for age, study sites, underlying medical conditions, smoking status, and hospital admissions over the past 12months.

RESULTS

The overall VE was -37.9% (95% CI: -103.3, 6.5) against laboratory-confirmed influenza-associated hospitalization. The 2015-16 seasonal vaccine was had -61.9% (95% CI: -211.9, 15.9), -5.4% (95% CI: -108.1, 46.6) and -45.2% (95% CI: -152.6, 16.5) effectiveness to prevent infection from A(H1N1)pdm09, A(H3N2) and influenza B, respectively.

CONCLUSIONS

Influenza vaccination did not show effective protection against hospitalization with influenza in 2015/16 season in Beijing.

摘要

背景

建议接种疫苗以预防流感病毒感染及相关并发症。本研究旨在评估2015/16赛季北京地区流感疫苗对住院治疗的有效性(VE)。

方法

招募了2015年10月1日至2016年5月15日期间在5家研究医院住院的患者。获取了经PCR确诊的流感患者以及病毒检测呈阴性的选定对照的流感疫苗接种状况。采用条件逻辑回归按日历周估算流感疫苗有效性,并对年龄、研究地点、基础疾病、吸烟状况以及过去12个月内的住院情况进行调整。

结果

针对实验室确诊的流感相关住院治疗,总体疫苗有效性为-37.9%(95%置信区间:-103.3, 6.5)。2015 - 16季节性疫苗对预防A(H1N1)pdm09、A(H3N2)和乙型流感感染的有效性分别为-61.9%(95%置信区间:-211.9, 15.9)、-5.4%(95%置信区间:-108.1, 46.6)和-45.2%(95%置信区间:-152.6, 16.5)。

结论

2015/16赛季在北京,流感疫苗接种对预防流感住院治疗未显示出有效保护作用。

相似文献

1
Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.2015/16年度中国北京流感疫苗对流感相关住院治疗的有效性
Vaccine. 2017 May 25;35(23):3129-3134. doi: 10.1016/j.vaccine.2017.03.084. Epub 2017 Apr 26.
2
Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.希腊六季(2013-2014 至 2018-2019 年)流感疫苗对住院确诊流感的有效性:一项汇总分析。
Vaccine. 2020 Mar 10;38(12):2715-2724. doi: 10.1016/j.vaccine.2020.01.083. Epub 2020 Feb 6.
3
Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.季节性流感疫苗对实验室确诊流感住院的效果-拉丁美洲,2013 年。
Vaccine. 2018 Jun 7;36(24):3555-3566. doi: 10.1016/j.vaccine.2017.06.036. Epub 2017 Jun 23.
4
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.在一个同时流行三种流感病毒型/亚型的季节里,对欧洲流感疫苗有效性的评估:I-MOVE 多中心病例对照研究,2012/13 年流感季节。
Euro Surveill. 2014 Feb 13;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701.
5
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.2014/15 年在欧洲,I-MOVE 多中心病例对照研究中,在甲型 H1N1pdm09、乙型和漂移型甲型 H3N2 流感共同流行的季节,初级保健患者中预防实验室确诊流感的疫苗效力。
Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139.
6
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.2012/13 年度流感疫苗对住院的甲型 H1N1pdm09、甲型 H3N2 和乙型流感的效果:来自一个欧洲医院网络的估计。
Euro Surveill. 2015 Jan 15;20(2):21011. doi: 10.2807/1560-7917.es2015.20.2.21011.
7
Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.三价季节性流感疫苗在英国初级保健中预防实验室确诊流感的效果:2012/13 季末结果。
Euro Surveill. 2014 Jul 10;19(27):5-13.
8
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.欧洲老年人重复接种季节性流感疫苗:对实验室确诊的流感住院病例的影响。
Vaccine. 2017 Aug 3;35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088. Epub 2017 Jul 11.
9
Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.2014/15 年度中国北京针对有医疗就诊记录的流感疾病的流感疫苗有效性。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2379-2384. doi: 10.1080/21645515.2017.1359364.
10
Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.2014-2015 年季节希腊通过实验室确诊流感住院的流感疫苗效果:一项病例对照研究。
J Med Virol. 2016 Nov;88(11):1896-904. doi: 10.1002/jmv.24551. Epub 2016 Apr 26.

引用本文的文献

1
Active Vaccine Safety Surveillance: Global Trends and Challenges in China.活性疫苗安全性监测:中国的全球趋势与挑战
Health Data Sci. 2021 Jun 12;2021:9851067. doi: 10.34133/2021/9851067. eCollection 2021.
2
The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review.中国流感流行病学及相关疫苗研发综述
Vaccines (Basel). 2022 Nov 6;10(11):1873. doi: 10.3390/vaccines10111873.
3
Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific.甲型H3N2流感病毒:西太平洋地区一项未得到解决的挑战。
Vaccines (Basel). 2022 Jan 12;10(1):112. doi: 10.3390/vaccines10010112.
4
Incidence, circulation, and spatiotemporal analysis of seasonal influenza in Shandong, China, 2008-2019: A retrospective study.2008-2019 年中国山东季节性流感的发病率、流行情况和时空分析:一项回顾性研究。
Influenza Other Respir Viruses. 2022 May;16(3):594-603. doi: 10.1111/irv.12959. Epub 2022 Jan 11.
5
Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review.健康孕妇和 5 岁以下儿童接种流感灭活疫苗的安全性、免疫原性、有效性和效果:基于证据的临床综述。
Front Immunol. 2021 Oct 6;12:744774. doi: 10.3389/fimmu.2021.744774. eCollection 2021.
6
Influenza Vaccine Effectiveness in Mainland China: A Systematic Review and Meta-Analysis.中国大陆流感疫苗的有效性:一项系统评价与荟萃分析
Vaccines (Basel). 2021 Jan 23;9(2):79. doi: 10.3390/vaccines9020079.
7
Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis.在中国内地为 60 岁及以上老年人引入国家季节性流感疫苗接种的成本效益:建模分析。
BMC Med. 2020 Apr 14;18(1):90. doi: 10.1186/s12916-020-01545-6.
8
Characteristics of Seasonal Influenza Virus Activity in a Subtropical City in China, 2013-2019.2013 - 2019年中国亚热带城市季节性流感病毒活动特征
Vaccines (Basel). 2020 Mar 1;8(1):108. doi: 10.3390/vaccines8010108.
9
A model of influenza infection and vaccination in children aged under 5 years in Beijing, China.中国北京 5 岁以下儿童流感感染和疫苗接种模型。
Hum Vaccin Immunother. 2020 Jul 2;16(7):1685-1690. doi: 10.1080/21645515.2019.1705692. Epub 2020 Jan 29.
10
The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.应用病例对照研究评估疫苗有效性:方法学系统综述。
Epidemiology. 2020 Jan;31(1):43-64. doi: 10.1097/EDE.0000000000001116.